DEF 14A: NorthView Acquisition Corp. Seeks Extension to Complete Business Combination with Profusa

NorthView Acquisition Corp. is seeking stockholder approval to extend the deadline for completing a business combination from September 22, 2024, to as late as March 22, 2025, to allow more time to finalize its merger with Profusa, Inc.

Summary

• NorthView Acquisition Corp. is holding a special meeting of stockholders on September 19, 2024, to vote on proposals to extend the date by which it must complete a business combination.
• The company is seeking to extend the deadline from September 22, 2024, monthly for up to six additional months, potentially until March 22, 2025.
• This extension requires amending the company's amended and restated certificate of incorporation and the Investment Management Trust Agreement.
• The purpose of the extension is to allow NorthView more time to complete its proposed business combination with Profusa, Inc.
• Stockholders have the right to redeem their public shares for cash in connection with the extension.
• The estimated per-share redemption price is approximately $11.73 based on the current amount in the Trust Account.
• The company's board believes there will not be sufficient time before September 22, 2024, to complete the Business Combination with Profusa.
• The company's sponsor will contribute $0.05 per month per outstanding public share for each month of extension.
• If the extension is not approved, the company will dissolve and liquidate, distributing the funds in the Trust Account to public stockholders.
• The affirmative vote of at least 65% of the company's outstanding shares is required to approve the extension proposal.

Sentiment

Score: 6

Explanation: The document is neutral in tone, presenting the facts of the proposed extension and the associated risks and benefits. The sentiment is slightly positive due to the company's continued efforts to complete a business combination, but tempered by the uncertainties and potential for liquidation.

Positives

• The extension provides stockholders with the opportunity to consider a business combination.
• Stockholders retain the right to redeem their shares if they do not approve of the business combination.
• The company's sponsor is willing to contribute additional funds to extend the deadline.
• The board believes that a business combination would be in the best interests of the stockholders.

Negatives

• If the extension is approved, the amount remaining in the Trust Account may be significantly reduced due to redemptions.
• There is no assurance that the company will be able to complete a business combination, even with the extension.
• If the company liquidates, the warrants will expire worthless.
• The per-share distribution from the Trust Account, if the Company liquidates, may be less than $10.10, plus interest, due to unforeseen claims of creditors.

Risks

• The amount remaining in the Trust Account may be significantly reduced due to redemptions.
• The company may need to obtain additional funds to complete a business combination, and there is no assurance that such funds will be available.
• The company may be subject to a new 1% U.S. federal excise tax on redemptions.
• The company may not be able to complete an initial business combination with a U.S. target company if such initial business combination is subject to U.S. foreign investment regulations and review by a U.S. government entity such as the Committee on Foreign Investment in the United States (CFIUS), or is ultimately prohibited.
• If the company is deemed to be an investment company under the Investment Company Act, compliance with these additional regulatory burdens would require additional expenses for which we have not allotted funds and may hinder our ability to consummate a business combination.

Future Outlook

The company intends to hold another stockholder meeting prior to the Extended Date to seek approval of the business combination with Profusa. If the extension is approved, the company will continue to work to consummate the business combination by the Extended Date.

Management Comments

• Our Board currently believes that there will not be sufficient time before September 22, 2024, to complete the Business Combination with Profusa.
• The Board has determined that it is in the best interests of our stockholders to extend the date by which the Company has to consummate a business combination in order that our stockholders have the opportunity to participate in our future investment.

Industry Context

SPACs often seek extensions to complete mergers due to regulatory hurdles, market conditions, or difficulties in target valuation. The extension allows NorthView to continue pursuing its merger with Profusa in a challenging market environment for SPACs.

Comparison to Industry Standards

• Many SPACs have sought extensions to complete their business combinations, reflecting the challenges in the current market.
• The $0.05 per share contribution by the sponsor is a common mechanism to incentivize stockholders to approve the extension.
• The redemption rights offered to stockholders are standard practice in SPAC transactions to protect investors' interests.

Stakeholder Impact

• Stockholders have the opportunity to vote on the extension and redeem their shares.
• If the extension is approved, stockholders retain the right to vote on the business combination.
• If the extension is not approved, stockholders will receive a pro rata share of the Trust Account funds upon liquidation.
• The company's sponsor, directors, and officers have a financial interest in the extension being approved.

Next Steps

• Stockholders vote on the extension proposal at the Special Meeting on September 19, 2024.
• If approved, the company will file an amendment to its charter.
• The company will continue to work to consummate the business combination with Profusa by the Extended Date.
• The company will hold another stockholder meeting to seek approval of the business combination.

Key Dates

Keywords

business combination, extension, redemption, trust account, Profusa, special meeting, liquidation, sponsor, amendment, stockholders